• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

再次行冠状动脉旁路移植术的时代——高级 PCI 时代。

Redo Coronary Artery Bypass Grafting in the era of Advanced PCI.

机构信息

School of Medicine, University of Liverpool, Liverpool, United Kingdom.

Department of Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.

出版信息

Braz J Cardiovasc Surg. 2022 Aug 16;37(4):546-553. doi: 10.21470/1678-9741-2019-0206.

DOI:10.21470/1678-9741-2019-0206
PMID:35976207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9423790/
Abstract

OBJECTIVE

To review the evidence behind the role and relevance of redo coronary artery bypass grafting (CABG) in the current practice of percutaneous coronary intervention (PCI).

METHODS

A comprehensive electronic literature search was performed to identify articles that discuss the practice of PCI and redo CABG in patients that require coronary revascularization. All relevant studies are summarized in narrative manner to reflect current indications and preference.

RESULTS

The advancement in utilization of PCI has reduced the rate of redo CABG in patients with previous CABG that requires revascularization of an already treated coronary disease or a new onset of coronary artery stenosis. Redo CABG is associated with satisfactory perioperative outcomes but higher mortality at immediate postoperative period when compared to PCI.

CONCLUSION

Redo CABG patients are less likely to develop comorbidities associated with revascularisation, but the operative mortality is higher and long-term survival rates are similar in comparison to PCI. There is a need for further research into the role of redo CABG in the current advanced practice of PCI.

摘要

目的

回顾在当前经皮冠状动脉介入治疗(PCI)实践中再次冠状动脉旁路移植术(CABG)的作用和相关性的证据。

方法

进行了全面的电子文献检索,以确定讨论需要冠状动脉血运重建的患者中进行 PCI 和再次 CABG 实践的文章。以叙述的方式总结所有相关研究,以反映当前的适应证和偏好。

结果

PCI 的应用不断进步,减少了既往 CABG 患者中再次 CABG 的比率,这些患者需要对已治疗的冠状动脉疾病或新出现的冠状动脉狭窄进行血运重建。与 PCI 相比,再次 CABG 围手术期结果令人满意,但术后即刻死亡率更高。

结论

与 PCI 相比,再次 CABG 患者发生与血运重建相关的合并症的可能性较小,但手术死亡率更高,长期生存率相似。需要进一步研究再次 CABG 在当前先进的 PCI 实践中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/271d58d7922c/rbccv-37-04-0546-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/c92647e1bd51/rbccv-37-04-0546-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/756a6210d47c/rbccv-37-04-0546-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/271d58d7922c/rbccv-37-04-0546-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/c92647e1bd51/rbccv-37-04-0546-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/756a6210d47c/rbccv-37-04-0546-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/763c/9423790/271d58d7922c/rbccv-37-04-0546-g03.jpg

相似文献

1
Redo Coronary Artery Bypass Grafting in the era of Advanced PCI.再次行冠状动脉旁路移植术的时代——高级 PCI 时代。
Braz J Cardiovasc Surg. 2022 Aug 16;37(4):546-553. doi: 10.21470/1678-9741-2019-0206.
2
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
3
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在冠状动脉血运重建中的比较:一项系统评价。
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
4
The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study:5 年随访:多血管病变糖尿病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术血运重建的比较。
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.
5
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗无保护左主干狭窄:NOBLE 随机非劣效性试验的 5 年更新结果。
Lancet. 2020 Jan 18;395(10219):191-199. doi: 10.1016/S0140-6736(19)32972-1. Epub 2019 Dec 23.
6
[Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].[经皮冠状动脉介入治疗或冠状动脉旁路移植术治疗无保护左主干冠状动脉分叉病变的长期预后比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):19-25. doi: 10.3760/cma.j.issn.0253-3758.2017.01.005.
7
Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干狭窄患者的比较:系统评价和荟萃分析。
JAMA Cardiol. 2017 Oct 1;2(10):1079-1088. doi: 10.1001/jamacardio.2017.2895.
8
Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.冠状动脉旁路移植术与经皮冠状动脉介入治疗对多支血管病变患者长期死亡率和发病率的影响:动脉搭桥和支架时代随机临床试验的荟萃分析。
JAMA Intern Med. 2014 Feb 1;174(2):223-30. doi: 10.1001/jamainternmed.2013.12844.
9
Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With and Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.伴有或不伴有糖尿病的左主干病变患者经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较:来自4项随机临床试验汇总分析的结果
Circulation. 2024 Apr 23;149(17):1328-1338. doi: 10.1161/CIRCULATIONAHA.123.065571. Epub 2024 Mar 11.
10
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.经皮冠状动脉介入治疗联合药物洗脱支架与冠状动脉旁路移植术治疗左主干冠状动脉疾病的比较:一项个体患者数据分析荟萃研究。
Lancet. 2021 Dec 18;398(10318):2247-2257. doi: 10.1016/S0140-6736(21)02334-5. Epub 2021 Nov 15.

引用本文的文献

1
Factors influencing the development of heart failure after PCI in patients with acute coronary syndrome: a meta-analysis.急性冠状动脉综合征患者经皮冠状动脉介入治疗后心力衰竭发生的影响因素:一项荟萃分析
Am J Transl Res. 2025 Apr 15;17(4):2352-2375. doi: 10.62347/FPXH3010. eCollection 2025.

本文引用的文献

1
Redo coronary artery bypass grafting.再次冠状动脉旁路移植术。
Indian J Thorac Cardiovasc Surg. 2018 Dec;34(Suppl 3):272-278. doi: 10.1007/s12055-018-0651-1. Epub 2018 Feb 17.
2
Risk Factors and Outcomes in Redo Coronary Artery Bypass Grafting.再次冠状动脉旁路移植术的风险因素和结果。
Heart Lung Circ. 2020 Mar;29(3):384-389. doi: 10.1016/j.hlc.2019.02.008. Epub 2019 Mar 4.
3
Incidence, Predictors, and Outcomes of In-Hospital Percutaneous Coronary Intervention Following Coronary Artery Bypass Grafting.冠状动脉旁路移植术后院内经皮冠状动脉介入治疗的发生率、预测因素和结局。
J Am Coll Cardiol. 2019 Feb 5;73(4):415-423. doi: 10.1016/j.jacc.2018.10.071.
4
Long-term graft patency after coronary artery bypass grafting: Effects of morphological and pathophysiological factors.冠状动脉旁路移植术后的长期移植血管通畅情况:形态学和病理生理学因素的影响
Anatol J Cardiol. 2018 Nov;20(5):275-282. doi: 10.14744/AnatolJCardiol.2018.51447.
5
Percutaneous coronary intervention due to chronic total occlusion in the left main coronary artery after bypass grafting: A feasible option in selected cases.冠状动脉搭桥术后左主干冠状动脉慢性完全闭塞的经皮冠状动脉介入治疗:特定病例中的可行选择。
Rev Port Cardiol (Engl Ed). 2018 Oct;37(10):865.e1-865.e4. doi: 10.1016/j.repc.2017.03.015. Epub 2018 Oct 21.
6
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
7
Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.冠状动脉旁路移植术中的桡动脉或隐静脉移植物。
N Engl J Med. 2018 May 31;378(22):2069-2077. doi: 10.1056/NEJMoa1716026. Epub 2018 Apr 30.
8
Mechanisms, Consequences, and Prevention of Coronary Graft Failure.冠状动脉移植失败的机制、后果与预防。
Circulation. 2017 Oct 31;136(18):1749-1764. doi: 10.1161/CIRCULATIONAHA.117.027597.
9
Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.经皮冠状动脉介入治疗和冠状动脉旁路移植术后重复血运重建的发生率、特征、预测因素和结果:SYNTAX 试验 5 年随访。
JACC Cardiovasc Interv. 2016 Dec 26;9(24):2493-2507. doi: 10.1016/j.jcin.2016.09.044.
10
Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.随机对照试验:双侧与单侧胸廓内动脉桥血管移植的比较。
N Engl J Med. 2016 Dec 29;375(26):2540-9. doi: 10.1056/NEJMoa1610021. Epub 2016 Nov 14.